Abstract
INTRODUCTION
Patients with pharmacotherapy-resistant localization-related epilepsy (LRE) may be candidates for surgical intervention if the seizure onset zone can be well localized. Long used in Europe, intracranial recording with stereoelectroencephalography (sEEG) is emerging as an alternative to subdural strip and grid techniques in North American centers.
METHODS
We reviewed our initial experience in a consecutive cohort of patients who underwent sEEG for extraoperative monitoring of LRE between May 2014 and September 2016.
RESULTS
>Fifty patients (37 adult, 13 pediatric) were implanted with 536 depth electrodes (mean 10.7 per patient, 7.9 per implanted hemisphere). Among 18 patients with suspected lesional epilepsy (including 3 with bilateral and 4 with multiple unilateral lesions), sEEG identified lesional foci in 16 (89%) cases (15 unifocal, 1 bitemporal). Two patients required further localization with subdural grids. Of 20 patients with nonlesional epilepsy, sEEG localized foci in 16 (80%) cases (13 unifocal, 2 bitemporal, 1 multifocal). Two patients had foci near eloquent cortex requiring grid placement for further mapping and two could not be focally localized. Finally, of 12 patients who had previous resections or ablations, sEEG localized foci in 11 (92%) cases (10 peri-cavity, 1 multifocal) and 1 was not focally localized. Complications were minor and rare. In 536 electrodes, there were no (0.0%) infections or symptomatic hemorrhages and 3 (0.6%) small, asymptomatic hemorrhages. One electrode was deflected into the subdural space during placement and 1 patient required replacement of 2 electrodes that were broken during seizures in the monitoring unit.
CONCLUSION
Robot-assisted sEEG is a safe and useful method for localizing epileptogenic foci in patients with lesional, nonlesional, and previously treated LRE. The success of seizure onset localization and safety compare favorably with invasive subdural monitoring. Longer clinical follow up will be required to determine whether sEEG monitoring improves long-term seizure freedom in these challenging epilepsy patients.